The pharmaceutical giant, still riding high on the sales of Comirnaty and Paxlovid, is looking to a future of innovative oncology drugs and vaccines based on mRNA technology.
Although Pfizer has dominated the headlines with Comirnaty, it’s not the only company that has created a COVID-19 vaccine using mRNA technology. The biotechnology company Moderna received FDA authorization for its own mRNA COVID-19 vaccine, Spikevax, in December 2021 for administration in individuals 18 years old and older.
The top pharmaceutical companies and brands in this year’s Outcomes Creativity Index elevated their messaging by breaking down barriers, debunking myths and giving patients a stronger voice.
Horizon Therapeutics achieved third place in the 2022 OCI top companies ranking namely for its “Gout Revisited” campaign, which seeks to remove the stigma of gout, a disease that has been largely coined as an affliction of the “overindulgent, rich white man.” Keli Walbert, executive vice president, U.S. Operations, at Horizon Therapeutics shared insights with MedAdNews about the company’s strategy in debunking gout myths and steering the message in the right direction.
Evofem’s bold campaign surrounding the first hormone-free contraception gel for women helped the company bring home leading industry awards and elevated Phexxi to the top prescription brand in the 2022 OCI. Katherine Atkinson, chief commercial officer at Evofem Biosciences, walked Med Ad Newsthrough the company’s conceptual journey of the campaign and what it meant to give women more control over their bodies – and their sexual and reproductive health.
Boehringer Ingelheim’s campaign for “The Unwearable Collection”, which worked to portray the patient experience of living with generalized pustular psoriasis (GPP), a painful skin disease, helped the company rise to the top half of the 2022 OCI company ranking. Claudia Beqaj, executive director, specialty marketing sales, dermatology at Boehringer Ingelheim, explained how the company took on the challenging mission of educating dermatologists about GPP in a more authentic and reverent way.
The top pharma companies in 2021 continued to be engaged in creating vaccines and therapeutics, and the investments in R&D led to greater revenue and earnings.
AbbVie may have doubled in size since the Allergan acquisition, but nearly half the company’s revenue, and a large chunk of its potential future growth, are still coming from a familiar place.
Amgen is equipped with a broad and diverse product portfolio, commercial capabilities, and levers for delivering mid-single digit revenue growth over this decade.
Alexion has boosted AstraZeneca’s rare disease expertise while the company has experienced success in oncology and COVID-19.
